KRAIG BIOCRAFT LABORATORIES, INC. Comprehensive Income
KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Comprehensive Income of -$433.20 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-11-13
- KRAIG BIOCRAFT LABORATORIES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$433.20K.
- KRAIG BIOCRAFT LABORATORIES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$1.61M.
- KRAIG BIOCRAFT LABORATORIES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$507.88K.
- KRAIG BIOCRAFT LABORATORIES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-12-31 was -$1.32M.
- KRAIG BIOCRAFT LABORATORIES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$3.03M.
- KRAIG BIOCRAFT LABORATORIES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$3.84M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$433.20K 10-Q · filed 2024-11-13 | -$2.04M derived: sum of 2 quarters · filed 2024-11-13 | -$2.55M 10-Q · filed 2024-11-13 | -$3.87M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | -$1.61M 10-Q · filed 2024-08-14 | -$2.11M 10-Q · filed 2024-08-14 | -$3.44M derived: sum of 3 quarters · filed 2024-08-14 | -$4.00M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | -$507.88K 10-Q · filed 2024-05-14 | -$1.83M derived: sum of 2 quarters · filed 2024-05-14 | -$2.39M derived: sum of 3 quarters · filed 2024-11-13 | -$2.97M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.89M derived: sum of 2 quarters · filed 2024-11-13 | -$2.46M derived: sum of 3 quarters · filed 2024-11-13 | -$3.03M 10-K · filed 2024-04-01 |
| 2023-09-30 | -$562.29K 10-Q · filed 2024-11-13 | -$1.14M derived: sum of 2 quarters · filed 2024-11-13 | -$1.71M 10-Q · filed 2024-11-13 | -$2.65M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$576.07K 10-Q · filed 2024-08-14 | -$1.14M 10-Q · filed 2024-08-14 | -$2.09M derived: sum of 3 quarters · filed 2024-08-14 | -$2.90M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$566.78K 10-Q · filed 2024-05-14 | -$1.51M derived: sum of 2 quarters · filed 2024-05-14 | -$2.32M derived: sum of 3 quarters · filed 2024-05-14 | -$3.36M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$946.85K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.76M derived: sum of 2 quarters · filed 2024-04-01 | -$2.80M derived: sum of 3 quarters · filed 2024-04-01 | -$3.84M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$810.36K 10-Q · filed 2023-11-13 | -$1.85M derived: sum of 2 quarters · filed 2023-11-13 | -$2.90M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$1.04M 10-Q · filed 2023-08-14 | -$2.08M 10-Q · filed 2023-08-14 |